## Abstract Because there is evidence that central cholinergic mechanisms are depleted in dementia, we studied the effects of central cholinergic augmentation on the memory of 5 patients with Alzheimer disease. Patients received placebo, lecithin, physostigmine, or lecithin plus physostigmine in a
Possible biochemical basis of memory disorder in Alzheimer disease
β Scribed by Dr. Christine M. Smith; Michael Swash
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 305 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. The objective of this study was to assess the rate of progression and clinical predictors of decline in subjects with `possible' and `probable' Alzheimer's disease (AD). Design/setting. The annual rate of change (ARC) for cognitive/functional scales was calculated for 95 subjects with AD
Background. Depressive illness (DI) and Alzheimer's disease (AD) are important causes of morbidity in old age and the relationships between these two disorders are uncertain. Method. In a prospective, descriptive, comparative study of consecutive referrals aged over 65 years to one consultant, 218